Eli Lilly and Company, UnitedHealth Group, Tempus AI, Gilead Sciences, Vertex Pharmaceuticals, Johnson & Johnson, and Walmart are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies operating in the healthcare sector—this includes pharmaceutical and biotechnology firms, medical device manufacturers, diagnostics companies, and healthcare service providers. By buying medical stocks, investors gain exposure to businesses developing drugs, therapies and medical technologies. Performance in this sector is often driven by factors such as regulatory approvals, patent developments and changes in healthcare policy. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
NYSE:LLY traded down $15.71 during trading hours on Friday, hitting $625.15. The company's stock had a trading volume of 14,089,857 shares, compared to its average volume of 4,833,475. The business's 50-day moving average is $774.10 and its two-hundred day moving average is $799.11. The company has a market capitalization of $592.48 billion, a PE ratio of 40.86, a PEG ratio of 0.89 and a beta of 0.44. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.06 and a current ratio of 1.37. Eli Lilly and Company has a 52-week low of $623.78 and a 52-week high of $972.53.
Read Our Latest Research Report on LLY
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
NYSE:UNH traded up $6.07 during trading hours on Friday, hitting $250.74. The company's stock had a trading volume of 10,146,688 shares, compared to its average volume of 18,404,546. The business's 50-day moving average is $291.78 and its two-hundred day moving average is $406.04. The company has a market capitalization of $227.46 billion, a PE ratio of 10.86, a PEG ratio of 1.62 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group has a 52-week low of $234.60 and a 52-week high of $630.73.
Read Our Latest Research Report on UNH
Tempus AI (TEM)
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
NASDAQ:TEM traded up $2.13 during trading hours on Friday, hitting $60.87. The company's stock had a trading volume of 26,073,235 shares, compared to its average volume of 8,255,315. The business's 50-day moving average is $62.47 and its two-hundred day moving average is $58.05. The company has a market capitalization of $10.54 billion, a PE ratio of -51.15 and a beta of 4.98. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.56 and a current ratio of 1.71. Tempus AI has a 52-week low of $31.36 and a 52-week high of $91.45.
Read Our Latest Research Report on TEM
Gilead Sciences (GILD)
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.
NASDAQ:GILD traded up $9.13 during trading hours on Friday, hitting $119.41. The company's stock had a trading volume of 13,112,190 shares, compared to its average volume of 5,807,634. The business's 50-day moving average is $110.93 and its two-hundred day moving average is $107.53. The company has a market capitalization of $148.54 billion, a PE ratio of 23.79, a PEG ratio of 0.75 and a beta of 0.33. The company has a debt-to-equity ratio of 1.16, a quick ratio of 1.23 and a current ratio of 1.37. Gilead Sciences has a 52-week low of $72.43 and a 52-week high of $121.38.
Read Our Latest Research Report on GILD
Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor.
Shares of VRTX stock traded down $9.09 during mid-day trading on Friday, reaching $366.54. The stock had a trading volume of 3,679,339 shares, compared to its average volume of 1,989,627. Vertex Pharmaceuticals has a 12-month low of $364.66 and a 12-month high of $519.88. The company has a market cap of $93.98 billion, a P/E ratio of 26.20 and a beta of 0.44. The business has a 50-day simple moving average of $450.77 and a 200 day simple moving average of $465.77.
Read Our Latest Research Report on VRTX
Johnson & Johnson (JNJ)
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.
Shares of JNJ stock traded up $1.87 during mid-day trading on Friday, reaching $173.40. The stock had a trading volume of 7,686,049 shares, compared to its average volume of 9,496,232. Johnson & Johnson has a 12-month low of $140.68 and a 12-month high of $173.96. The company has a market cap of $417.61 billion, a P/E ratio of 18.55, a price-to-earnings-growth ratio of 2.21 and a beta of 0.41. The business has a 50-day simple moving average of $159.26 and a 200 day simple moving average of $157.52. The company has a current ratio of 1.01, a quick ratio of 0.76 and a debt-to-equity ratio of 0.50.
Read Our Latest Research Report on JNJ
Walmart (WMT)
Walmart Inc. engages in the operation of retail, wholesale, other units, and eCommerce worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores under Walmart and Walmart Neighborhood Market brands; membership-only warehouse clubs; ecommerce websites, such as walmart.com.mx, walmart.ca, flipkart.com, PhonePe and other sites; and mobile commerce applications.
Shares of WMT stock traded up $0.65 during mid-day trading on Friday, reaching $103.77. The stock had a trading volume of 12,392,140 shares, compared to its average volume of 14,088,264. Walmart has a 12-month low of $67.14 and a 12-month high of $105.30. The company has a market cap of $828.13 billion, a P/E ratio of 44.35, a price-to-earnings-growth ratio of 4.99 and a beta of 0.66. The business has a 50-day simple moving average of $97.30 and a 200 day simple moving average of $95.38. The company has a current ratio of 0.78, a quick ratio of 0.22 and a debt-to-equity ratio of 0.47.
Read Our Latest Research Report on WMT
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Eli Lilly and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.
While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
